{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:12:06Z","timestamp":1760955126745},"reference-count":32,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.jviromet.2009.01.017","type":"journal-article","created":{"date-parts":[[2009,1,31]],"date-time":"2009-01-31T09:46:52Z","timestamp":1233395212000},"page":"84-92","source":"Crossref","is-referenced-by-count":11,"title":["Potency evaluation of rabies vaccine for human use: The impact of the reduction in the number of animals per dilution"],"prefix":"10.1016","volume":"158","author":[{"given":"Wlamir Corr\u00eaa de","family":"Moura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto Pinheiro de","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Hernan","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis Catharina","family":"Romijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Paulo Gagliardi","family":"Leite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2009.01.017_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","article-title":"NIH test, a problematic method for testing potency of inactivated rabies vaccine","volume":"6","author":"Barth","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.01.017_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2009.01.017_bib3","doi-asserted-by":"crossref","unstructured":"Bland, J.M., Altman, D.G., 1996. Statistics Notes: Measurement Error. BJM, 313, 744. Available at: http:\/\/www.bmj.com\/cgi\/content\/full\/313\/7059\/744","DOI":"10.1136\/bmj.313.7059.744"},{"key":"10.1016\/j.jviromet.2009.01.017_bib4","unstructured":"Bland, J.M., 2005. How should I calculate a within-subject coefficient of variation? Available at: http:\/\/www-users.york.ac.uk\/\u223cmb55\/meas\/cv.htm"},{"key":"10.1016\/j.jviromet.2009.01.017_bib5","first-page":"429","article-title":"Three Rs approaches in the quality control of inactivated Rabies vaccines","volume":"31","author":"Bruckner","year":"2003","journal-title":"ATLA"},{"key":"10.1016\/j.jviromet.2009.01.017_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF01941183","article-title":"Reduction in the number of mice used for potency testing of human and animal rabies vaccines","volume":"44","author":"Bruckner","year":"1988","journal-title":"Experientia"},{"key":"10.1016\/j.jviromet.2009.01.017_bib7","unstructured":"Council of Europe, 2008a. Rabies vaccine (inactivated) for veterinary use (Monograph no. 0451). In: The European Pharmacopoeia, 6th ed., Strasbourg, France, pp. 790\u2013792."},{"key":"10.1016\/j.jviromet.2009.01.017_bib8","unstructured":"Council of Europe. 2008b. Rabies vaccine for human use prepared in cell cultures (Monograph no. 0216). In: The European Pharmacopoeia, 6th ed., Strasbourg, France, pp. 836\u2013838."},{"key":"10.1016\/j.jviromet.2009.01.017_bib9","unstructured":"Council of Europe. 2008c. Assays depending upon quantal responses. In: The European Pharmacopoeia, 6th ed., Strasbourg, France, pp. 580\u2013582 (Chapter 4 \u2013 General texts)."},{"key":"10.1016\/j.jviromet.2009.01.017_bib10","unstructured":"Farmacop\u00e9ia Brasileira, Fasc\u00edculo 5, 2004. 4a Edi\u00e7\u00e3o, parte II \u2013 Vacina Contra Raiva Uso Humano, mon. 120. Atheneu Ed. S\u00e3o Paulo, SP."},{"key":"10.1016\/j.jviromet.2009.01.017_bib11","first-page":"183","article-title":"Use of the antibody assay in immunized mice for the determination of rabies vaccine potency","volume":"40","author":"Fitzgerald","year":"1978","journal-title":"Develop. Biol. Stand."},{"key":"10.1016\/j.jviromet.2009.01.017_bib12","series-title":"Methods in Molecular Medicine: Vaccine Protocols","article-title":"Assuring the quality of vaccines: regulatory requirements for licensing and batch release","author":"Griffiths","year":"1996"},{"key":"10.1016\/j.jviromet.2009.01.017_bib13","first-page":"747","article-title":"Validation of alternative methods for the potency testing of vaccines","volume":"26","author":"Hendriksen","year":"1998","journal-title":"ATLA"},{"key":"10.1016\/j.jviromet.2009.01.017_bib14","first-page":"575","article-title":"Three Rs achievements in vaccinology","volume":"14","author":"Hendriksen","year":"2007","journal-title":"AATEX"},{"issue":"2","key":"10.1016\/j.jviromet.2009.01.017_bib15","first-page":"53","article-title":"Reduction of numbers of animals used in the Quality Control of Biologicals","volume":"32","author":"Hendriksen","year":"2004","journal-title":"ATLA"},{"key":"10.1016\/j.jviromet.2009.01.017_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-1157(87)80008-2","article-title":"The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European Pharmacop\u0153ia","volume":"15","author":"Hendriksen","year":"1987","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.jviromet.2009.01.017_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.jviromet.2009.01.017_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2307\/2532051","article-title":"A concordance correlation coefficient to evaluate reproducibility","volume":"45","author":"Lin","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.jviromet.2009.01.017_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2307\/2532314","article-title":"Assay validation using the concordance correlation coefficient","volume":"48","author":"Lin","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.jviromet.2009.01.017_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1097-0258(20000130)19:2<255::AID-SIM293>3.0.CO;2-8","article-title":"Total deviation index for measuring individual agreement with applications in laboratory performance and bioequivalence","volume":"19","author":"Lin","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.jviromet.2009.01.017_bib21","series-title":"Cohen's Kappa for Dichotomous Variables","article-title":"Using Statistical Methods for Water Quality Management. Issues problems and solutions","author":"McBride","year":"2005"},{"key":"10.1016\/j.jviromet.2009.01.017_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0020-7519(03)00067-5","article-title":"A review of the effectiveness of vaccine potency control testing","volume":"33","author":"McVey","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.jviromet.2009.01.017_bib23","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/S0264-410X(02)00192-5","article-title":"Reduction of animal use in human vaccine quality control: opportunities and problems","volume":"20","author":"Metz","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.01.017_bib24","unstructured":"OIE (Office International des Epizooties), 2004. Paris, France, Rabies, in Manual of standards for diagnostic test and vaccines. Available at: http:\/\/www.oie.int\/eng\/\/normes\/mmanual\/A_00044.htm"},{"issue":"11","key":"10.1016\/j.jviromet.2009.01.017_bib25","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/clinchem\/43.11.2039","article-title":"Graphical interpretation of analytical data from comparison of field method with reference method by use of difference plots","volume":"Vol. 43","author":"Petersen","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jviromet.2009.01.017_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/biol.2000.0247","article-title":"The Pertussis Serological Potency test collaborative study to evaluate replacement of the mouse protection test","volume":"28","author":"van der Ark","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2009.01.017_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1183\/09031936.01.00203101","article-title":"The repeatability of nonbronchoscopic bronchoalveolar lavage differential cell counts","volume":"18","author":"Warke","year":"2001","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jviromet.2009.01.017_bib28","series-title":"Laboratory Techniques in Rabies","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996"},{"key":"10.1016\/j.jviromet.2009.01.017_bib29","series-title":"Animal Welfare Aspects in the Quality Control of Immunologicals. A Critical Evaluation of Animal Tests in Pharmacopoeial monographs","author":"Weisser","year":"1997"},{"key":"10.1016\/j.jviromet.2009.01.017_bib30","unstructured":"World Health Organization, 1997a. WHO guide to good manufacturing practice (GMP) requirements. Part 2. Validation. Chapter 15. Validation of analytical assays. Geneva: pp. 69\u201373."},{"key":"10.1016\/j.jviromet.2009.01.017_bib31","unstructured":"World Health Organization, 1997b. BLG 97.4. Manual of laboratory methods for potency testing of vaccines used in the WHO expanded program on immunization. Chapter 27. Use and validation of a single vaccine dilution assay for testing the potency of Diphtheria, Tetanus and combined vaccines, pp. 162\u2013174."},{"key":"10.1016\/j.jviromet.2009.01.017_bib32","unstructured":"World Health Organization, 2007. Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs. WHO Technical Report Series, No. 941. Geneva, pp. 109\u2013110."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609340900024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016609340900024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:06:01Z","timestamp":1589526361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016609340900024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S016609340900024X"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2009.01.017","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}